| Weekly and monthly subcutaneous buprenorphine depot formulations vs daily sublingual buprenorphine with naloxone for treatment of opioid use disorder: a randomized clinical trial MR Lofwall, SL Walsh, EV Nunes, GL Bailey, SC Sigmon, KM Kampman, ... JAMA internal medicine 178 (6), 764-773, 2018 | 268 | 2018 |
| A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world MR Lofwall, SL Walsh Journal of addiction medicine 8 (5), 315-326, 2014 | 267 | 2014 |
| Oral cannabidiol does not alter the subjective, reinforcing or cardiovascular effects of smoked cannabis M Haney, RJ Malcolm, S Babalonis, PA Nuzzo, ZD Cooper, G Bedi, ... Neuropsychopharmacology 41 (8), 1974-1982, 2016 | 209 | 2016 |
| Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users JR Havens, MR Lofwall, SDW Frost, CB Oser, CG Leukefeld, RA Crosby American journal of public health 103 (1), e44-e52, 2013 | 209 | 2013 |
| The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers SL Walsh, PA Nuzzo, MR Lofwall, JR Holtman Jr Drug and alcohol dependence 98 (3), 191-202, 2008 | 183 | 2008 |
| Buprenorphine pharmacology review: update on transmucosal and long-acting formulations MA Coe, MR Lofwall, SL Walsh Journal of addiction medicine 13 (2), 93-103, 2019 | 162 | 2019 |
| Abuse liability and reinforcing efficacy of oral tramadol in humans S Babalonis, MR Lofwall, PA Nuzzo, AJ Siegel, SL Walsh Drug and alcohol dependence 129 (1-2), 116-124, 2013 | 160 | 2013 |
| Effect of buprenorphine implants on illicit opioid use among abstinent adults with opioid dependence treated with sublingual buprenorphine: a randomized clinical trial RN Rosenthal, MR Lofwall, S Kim, M Chen, KL Beebe, FJ Vocci, ... Jama 316 (3), 282-290, 2016 | 151 | 2016 |
| Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers S Babalonis, M Haney, RJ Malcolm, MR Lofwall, VR Votaw, S Sparenborg, ... Drug and alcohol dependence 172, 9-13, 2017 | 147 | 2017 |
| A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults KM Gray, SC Sonne, EA McClure, UE Ghitza, AG Matthews, ... Drug and alcohol dependence 177, 249-257, 2017 | 144 | 2017 |
| Characteristics of older opioid maintenance patients MR Lofwall, RK Brooner, GE Bigelow, K Kindbom, EC Strain Journal of Substance Abuse Treatment 28 (3), 265-272, 2005 | 130 | 2005 |
| Individual and network factors associated with non-fatal overdose among rural Appalachian drug users JR Havens, CB Oser, HK Knudsen, M Lofwall, WW Stoops, SL Walsh, ... Drug and alcohol dependence 115 (1-2), 107-112, 2011 | 122 | 2011 |
| Effect of buprenorphine weekly depot (CAM2038) and hydromorphone blockade in individuals with opioid use disorder: a randomized clinical trial SL Walsh, SD Comer, MR Lofwall, B Vince, N Levy-Cooperman, D Kelsh, ... JAMA psychiatry 74 (9), 894-902, 2017 | 105 | 2017 |
| The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers LS Middleton, PA Nuzzo, MR Lofwall, DE Moody, SL Walsh Addiction 106 (8), 1460-1473, 2011 | 102 | 2011 |
| The changing landscape of naloxone availability in the United States, 2011–2017 PR Freeman, ER Hankosky, MR Lofwall, JC Talbert Drug and alcohol dependence 191, 361-364, 2018 | 96 | 2018 |
| Inability to access buprenorphine treatment as a risk factor for using diverted buprenorphine MR Lofwall, JR Havens Drug and alcohol dependence 126 (3), 379-383, 2012 | 96 | 2012 |
| Physical dependence potential of daily tramadol dosing in humans RK Lanier, MR Lofwall, MZ Mintzer, GE Bigelow, EC Strain Psychopharmacology 211, 457-466, 2010 | 96 | 2010 |
| Intravenous oxycodone, hydrocodone, and morphine in recreational opioid users: abuse potential and relative potencies WW Stoops, KW Hatton, MR Lofwall, PA Nuzzo, SL Walsh Psychopharmacology 212, 193-203, 2010 | 91 | 2010 |
| Abuse and diversion of gabapentin among nonmedical prescription opioid users in Appalachian Kentucky RV Smith, MR Lofwall, JR Havens American Journal of Psychiatry 172 (5), 487-488, 2015 | 90 | 2015 |
| Association of naloxone coprescription laws with naloxone prescription dispensing in the United States M Sohn, JC Talbert, Z Huang, MR Lofwall, PR Freeman JAMA network open 2 (6), e196215-e196215, 2019 | 88 | 2019 |
